Digital Health: Access to Care and the Generational Divide

Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

‘Unbelievably good price’: KC-area pharmacy dispenses bargain medicine — and hope Go to article

Charitable Pharmacies of America organization member receives Health Equity grant

Three Healthcare Organizations Join Forces to Save Lives

Starting Sept. 25, Americans can again order free COVID-19 tests through the federal government.

One in four Americans say they struggle to afford their prescription medications. The establishment of this Charitable Pharmacy in Milford will allow patients who live east of Cincinnati better access to care.

FDA approves 1 Year delay of Track & Trace requirements

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?

The term digital divide is defined as the differences
of economic and social inequality in both access and usage of ICTs. 2, 3 Some population groups that are
affected by the digital divide include uninsured, at or below 300% of the Federal Poverty Level (FPL), lack
of internet access, etc

Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections

NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.